Cover Image
市場調查報告書

美國的機器式心臟瓣膜市場分析

US Market Report for Mechanical Heart Valves 2018 - MedCore

出版商 iData Research Inc. 商品編碼 590189
出版日期 內容資訊 英文 386 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
美國的機器式心臟瓣膜市場分析 US Market Report for Mechanical Heart Valves 2018 - MedCore
出版日期: 2017年12月01日 內容資訊: 英文 386 Pages
簡介

本報告提供美國國內的機器式 (人工) 心臟瓣膜的市場相關分析,彙整整體市場結構和近來主要的事件關聯性,市場規模的轉變及預測 (過去4年·今後7年份),推動及阻礙市場要素,近幾年的企業間競爭·資本交易情勢,主要企業的簡介等資訊,為您概述為以下內容。

摘要整理

美國的心血管手術·心臟瓣膜設備市場概要

競爭分析

市場趨勢

市場發展

治療數量

分析對象的治療編碼

分析對象市場

主要報告的更新情形

過去的版本

分析方法

  • 分析範圍
  • IDATA的9級分析方法

疾病概要

  • 人體結構
    • 冠狀動脈疾病
    • 心肌梗塞
    • 心絞痛
    • 心臟瓣膜症
    • 充血性心臟衰竭

產品系列

  • 簡介
    • 組織心臟瓣膜
    • 機器心臟瓣膜
    • 瓣環成形術 (修復)
    • 經導管二尖瓣瓣膜修復術
    • 經導管置換心瓣膜手術術
    • 體外循環輔助下冠狀動脈繞道手術 (ONCAB) 設備
    • 非體外循環冠狀動脈繞道手術 (OPCAB) 設備
    • EVH (內視鏡取血管手術) 設備
    • 吻合補助設備
    • 經心肌血液循環重組設備
    • 心室補助設備
    • 大主動脈內氣球幫浦 設備
    • 人工心臟設備
    • 血液循環動態遠程監控系統
    • 心房中隔缺損 (ASD)/心室中隔缺損 (VSD) 設備
    • 左心房封閉設備
    • EMOM (體外式薄膜型人工肺)
  • FDA (美國食品藥物管理局) 的回收
    • MAQUET
    • Medtronic
    • HeartWare Inc
  • 臨床實驗趨勢
    • Medtronic
    • St. Jude Medical
    • Abiomed
    • Heartware Inc

機器式心臟瓣膜市場

  • 簡介
  • 市場概要
  • 市場分析與預測
    • 整體市場規模
    • 無導管機械瓣膜市場
    • 附導管機械瓣膜市場
  • 推動及阻礙市場要素
    • 推動市場要素
    • 阻礙市場要素
  • 各企業市場佔有率分析

簡稱一覽

附錄·各企業的新聞稿一覽

目錄
Product Code: iDATA_USCS18_MC_MHV

Mechanical heart valves are prosthetic devices designed to replicate the function of the natural valves of the human heart. Mechanical valves are designed to outlast the patient and some have been stress-tested to last several hundred years. Although mechanical valves are long-lasting and generally only require one surgery for installation, they contribute to an increased risk of blood clot formation. As a result, mechanical valve recipients often take anti-coagulant (blood thinning) drugs such as warfarin for the rest of their lives, which makes the patient more prone to bleeding. Given their durability, mechanical valves are primarily indicated for younger patients and for mitral valve replacement due to its high-pressure gradient. The primary advantage of mechanical over tissue valves is that once a mechanical valve is implanted, they never wear down and rarely need to be replaced. Mechanical valves are made from either pyrolytic carbon or titanium that has been coated with pyrolytic carbon. Pyrolytic carbon is similar to graphite and is used for many biomedical applications. They also can have parts made from Teflon, polyester or polyethylene terephthalate.

The first generation of device designs for mechanical heart valves included a caged-ball construct. These devices functioned similar in fashion to a ballpoint pen, serving as a one-way flow point for blood between the chambers of the heart. However, this design was not ideal in that the heart had to work harder to maintain flow through the valve. Subsequent generations of device design focused on an open-and-close valve, which allowed for central blood flow. Mechanical heart valves may be combined with a conduit for use in cases requiring the reconstruction of both the aortic heart valve and the aorta.

Table of Contents

TABLE OF CONTENTS I

LIST OF FIGURES XII

LIST OF CHARTS XV

EXECUTIVE SUMMARY 1

U.S. CARDIAC SURGERY AND HEART VALVE DEVICE MARKET OVERVIEW 1

COMPETITIVE ANALYSIS 4

MARKET TRENDS 7

MARKET DEVELOPMENTS 11

PROCEDURE NUMBERS 12

PROCEDURE CODES INVESTIGATED 16

MARKETS INCLUDED 17

KEY REPORT UPDATES 19

VERSION HISTORY 20

RESEARCH METHODOLOGY 21

    • Step 1: Project Initiation & Team Selection 21
    • Step 2: Prepare Data Systems and Perform Secondary Research 24
    • Step 3: Preparation for Interviews & Questionnaire Design 26
    • Step 4: Performing Primary Research 27
    • Step 5: Research Analysis: Establishing Baseline Estimates 29
    • Step 6: Market Forecasts and Analysis 30
    • Step 7: Identify Strategic Opportunities 32
    • Step 8: Final Review and Market Release 33
    • Step 9: Customer Feedback and Market Monitoring 34

DISEASE OVERVIEW 35

  • 2.1 BASIC ANATOMY 35
    • 2.1.11 Coronary Artery Disease 37
    • 2.1.12 Myocardial Infarction 37
    • 2.1.13 Angina Pectoris 38
    • 2.1.14 Heart Valve Disease 39
    • 2.1.15 Congestive Heart Failure 39

PRODUCT PORTFOLIO 41

    • 3.1.1 Tissue Heart Valves 41
    • 3.1.2 Mechanical Tissue Heart Valves 43
    • 3.1.3 Annuloplasty Repair Devices 45
    • 3.1.4 Transcatheter Aortic Valve Replacement Devices 47
    • 3.1.5 Transcatheter Mitral Valve Repair Devices 49
    • 3.1.6 On-Pump Coronary Artery Bypass Devices 50
    • 3.1.7 Off-Pump Coronary Artery Bypass Devices 52
    • 3.1.8 Endoscopic Vessel Harvesting Devices 53
    • 3.1.9 Anastomosis Assist Devices 54
    • 3.1.10 Transmyocardial Revascularization Devices 55
    • 3.1.11 Ventricular Assist Devices 56
    • 3.1.12 Intra-Aortic Balloon Pump Device 57
    • 3.1.13 Temporary Artificial Heart Replacement Device 58
    • 3.1.14 Remote Hemodynamic Monitoring System Devices 59
    • 3.1.15 Patent Foramen Ovale Devices 59
    • 3.1.16 Atrial & Ventricular Septal Defect Device 61
    • 3.1.17 Left Atrial Appendage Closure Device 62
    • 3.1.18 Extracorporeal Membrane Oxygenation Machine 63
  • 3.2 FDA RECALLS 64
    • 3.2.1 MAQUET 64
    • 3.2.2 Medtronic 66
    • 3.2.3 HeartWare Inc 67
  • 3.3 CLINICAL TRIALS 68
    • 3.3.1 Medtronic 68
    • 3.3.2 St. Jude Medical 70
    • 3.3.3 Abiomed 75
    • 3.3.4 Heartware Inc 76

MECHANICAL HEART VALVE MARKET 78

  • 4.1 INTRODUCTION 78
  • 4.2 MARKET OVERVIEW 80
  • 4.3 MARKET ANALYSIS AND FORECAST 83
    • 4.3.1 Total Mechanical Heart Valve Market 83
    • 4.3.2 Mechanical Heart Valve without Conduit Market 85
    • 4.3.3 Mechanical Heart Valve with Conduit Market 87
  • 4.4 DRIVERS AND LIMITERS 89
    • 4.4.1 Market Drivers 89
    • 4.4.2 Market Limiters 89
  • 4.5 COMPETITIVE MARKET SHARE ANALYSIS 91

ABBREVIATIONS 94

APPENDIX: COMPANY PRESS RELEASES 97

LIST OF CHARTS

  • Chart 1 1: Cardiac Surgery and Heart Valve Devices Market by Segment, U.S., 2014 - 2024 3
  • Chart 1 2: Cardiac Surgery and Heart Valve Devices Market Overview, U.S., 2017 & 2024 3
  • Chart 4 1: Mechanical Heart Valve Market by Segment, U.S., 2014 - 2024 81
  • Chart 4 2: Mechanical Heart Valve Market Breakdown by Segment, U.S., 2017 82
  • Chart 4 3: Mechanical Heart Valve Market Breakdown by Segment, U.S., 2024 82
  • Chart 4 4: Total Mechanical Heart Valve Market, U.S., 2014 - 2024 84
  • Chart 4 5: Mechanical Heart Valve without Conduit Market, U.S., 2014 - 2024 86
  • Chart 4 6: Mechanical Heart Valve with Conduit Market, U.S., 2014 - 2024 88
  • Chart 4 7: Leading Competitors, Mechanical Heart Valve Market, U.S., 2017 93

LIST OF FIGURES

  • Figure 1 1: Cardiac Surgery and Heart Valve Devices Market Share Ranking by Segment, U.S., 2017 (1 of 4) 4
  • Figure 1 2: Cardiac Surgery and Heart Valve Devices Market Share Ranking by Segment, U.S., 2017 (2 of 4) 5
  • Figure 1 3: Cardiac Surgery and Heart Valve Devices Market Share Ranking by Segment, U.S., 2017 (3 of 4) 5
  • Figure 1 4: Cardiac Surgery and Heart Valve Devices Market Share Ranking by Segment, U.S., 2017 (4 of 4) 5
  • Figure 1 5: Companies Researched in this Report, U.S., 2017 6
  • Figure 1 6: Factors Impacting the Cardiac Surgery and Heart Valve Devices Market by Segment, U.S. (1 of 4) 7
  • Figure 1 7: Factors Impacting the Cardiac Surgery and Heart Valve Devices Market by Segment, U.S. (2 of 4) 8
  • Figure 1 8: Factors Impacting the Cardiac Surgery and Heart Valve Devices Market by Segment, U.S. (3 of 4) 9
  • Figure 1 9: Factors Impacting the Cardiac Surgery and Heart Valve Devices Market by Segment, U.S. (4 of 4) 10
  • Figure 1 10: Recent Events in the Cardiac Surgery and Heart Valve Devices Market, U.S., 2015 - 2017 11
  • Figure 1 11: Cardiac Surgery and Heart Valve Devices Procedures Covered, U.S., 2017 (1 of 4) 12
  • Figure 1 12: Cardiac Surgery and Heart Valve Devices Procedures Covered, U.S., 2017 (2 of 4) 13
  • Figure 1 13: Cardiac Surgery and Heart Valve Devices Procedures Covered, U.S., 2017 (3 of 4) 14
  • Figure 1 14: Cardiac Surgery and Heart Valve Devices Procedures Covered, U.S., 2017 (4 of 4) 15
  • Figure 1 15: Procedure Codes Investigated, U.S., 2017 16
  • Figure 1 16: Cardiac Surgery and Heart Valve Devices Markets Covered, U.S., 2017 (1 of 2) 17
  • Figure 1 17: Cardiac Surgery and Heart Valve Devices Markets Covered, U.S., 2017 (2 of 2) 18
  • Figure 1 18: Key Report Updates (1 of 2) 19
  • Figure 1 19: Key Report Updates (2 of 2) 20
  • Figure 1 20: Version History 20
  • Figure 3 1: Tissue Heart Valves by Company 42
  • Figure 3 2: Mechanical Tissue Heart Valves by Company 44
  • Figure 3 3: Annuloplasty Repair Devices by Company 46
  • Figure 3 4: Transcatheter Heart Valve Replacement Devices by Company 48
  • Figure 3 5: Transcatheter Mitral Valve Repair Devices by Company 49
  • Figure 3 6: On-Pump Coronary Artery Bypass Devices by Company 51
  • Figure 3 7: Off-Pump Coronary Artery Bypass Devices by Company 52
  • Figure 3 8: Endoscopic Vessel Harvesting Devices by Company 53
  • Figure 3 9: Anastomosis Assist Devices by Company 54
  • Figure 3 10: Transmyocardial Revascularization Devices by Company 55
  • Figure 3 11: Ventricular Assist Devices by Company 56
  • Figure 3 12: Intra-Aortic Balloon Devices by Company 57
  • Figure 3 13: Temporary Artificial Heart Replacement Devices by Company 58
  • Figure 3 14: Remote Hemodynamic Monitoring System Devices by Company 59
  • Figure 3 15: Patent Foramen Ovale Devices by Company 60
  • Figure 3 16: Atrial & Ventricular Septal Defect Devices by Company 61
  • Figure 3 17: Left Atrial Appendage Closure Devices by Company 62
  • Figure 3 18: Extracorporeal Membrane Oxygenation Machine by Company 63
  • Figure 3 19: Class 2 Device Recall MAQUET 64
  • Figure 3 20: Class 2 Device Recall MAQUET 64
  • Figure 3 21: Class 2 Device Recall MAQUET 65
  • Figure 3 22: Class 1 Device Recall Medtronic 66
  • Figure 3 23: Class 1 Device Recall Heartware Inc 67
  • Figure 3 24: The Medtronic Harmony™ Transcatheter Pulmonary Valve Clinical Study 68
  • Figure 3 25: Medtronic Transcatheter Aortic Valve Implant System (CoreValve System Family) Post Marketing Surveillance 68
  • Figure 3 26: Medtronic CoreValve Evolut R U.S. Clinical Study 69
  • Figure 3 27: Medtronic Transcatheter Aortic Valve Replacement in Low Risk Patients 69
  • Figure 3 28: AMPLATZER™ Post-infarct Muscular VSD Occluder Humanitarian Device Exemption 70
  • Figure 3 29: AMPLATZER Duct Occluder II Additional Sizes (ADO II AS) 70
  • Figure 3 30: HeartMate 3 CE Mark Study Long Term Follow-up (HM3 CE LTFU) 71
  • Figure 3 31: Trifecta™ GT Post Market Clinical Follow-up 71
  • Figure 3 32: AMPLATZER™ LAA Occluder Post Approval Study (PAS) 72
  • Figure 3 33: AMPLATZER™ Cardiac Plug Observational Post-Approval Study (ACP PAS China) 72
  • Figure 3 34: MOMENTUM 3 Continued Access Protocol (MOMENTUM 3 CAP) 73
  • Figure 3 35: AMPLATZER™ Amulet™ LAA Occluder Trial (Amulet IDE) 73
  • Figure 3 36: Prevention of Non-Surgical Bleeding by Management of HeartMate II 74
  • Figure 3 37: Door To Unloading With IMPELLA CP System in Acute Myocardial Infarction (DTU) 75
  • Figure 3 38: Protected PCI Study 75
  • Figure 3 39: Assessment of the WATCHMAN™ Device 76
  • Figure 3 40: Watchman FLX Left Atrial Appendage Closure Device Post Approval Study 76
  • Figure 3 41: Investigational Device Evaluation of the WATCHMAN FLX™ LAA Closure Technology 77
  • Figure 4 1: Mechanical Heart Valve Market by Segment, U.S., 2014 - 2024 (US$M) 80
  • Figure 4 2: Total Mechanical Heart Valve Market, U.S., 2014 - 2024 83
  • Figure 4 3: Mechanical Heart Valve without Conduit Market, U.S., 2014 - 2024 85
  • Figure 4 4: Mechanical Heart Valve with Conduit Market, U.S., 2014 - 2024 87
  • Figure 4 5: Drivers and Limiters, Mechanical Heart Valve Market, U.S., 2017 90
  • Figure 4 6: Leading Competitors, Mechanical Heart Valve Market, U.S., 2017 92
  • Figure 6 1: Press Release Summary 97
Back to Top